MedPath

Nasal High-frequency Oscillatory Ventilation (NHFOV) for Ventilated Newborn Infants With BPD

Not Applicable
Recruiting
Conditions
Nasal High-frequency Oscillatory Ventilation
Bronchopulmonary Dysplasia
Neonate
Nasal Continuous Positive Airway Pressure
Interventions
Device: NHFOV
Device: NCPAP
Registration Number
NCT04905732
Lead Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Brief Summary

Invasive ventilation(IV) remains one key cornerstone to reduce neonatal mortality for preterm infants with respiratory distress syndrome(RDS) and/or acute respiratory distress syndrome(ARDS). However, it is also related to increased risks of ventilator-associated lung injury and escalation of pulmonary inflammation, and which finally result in bronchopulmonary dysplasia (BPD). Early weaning from IV in newborn infants with BPD is therefore a key procedure to reduce these risks above.

Detailed Description

Supplying with the combined advantages of NCPAP and high-frequency oscillatory ventilation (HFOV) with high carbon dioxide(CO2) removal, no need for synchronisation, non-invasion, less volume/barotraumas, and increased functional residual capacity, nasal HFOV(NHFOV) was considered as a strengthened version of NCPAP. Furthermore, the superimposed oscillations of NHFOV could avoid gas-trapping, and allowed to obviously up-regulate mean airway pressure (MAP) more than NCPAP. Thus, NHFOV might be more beneficial as post-extubation respiratory support strategy to avoid re-intubation and subsequent complications and/or sequelae as compared with NCPAP in preterm infants. Nowadays, NHFOV was increasingly used in neonatal intensive care unit (NICU) around the world due to its convenient operation. A retrospective review has reported the beneficial effects of NHFOV in preterm infants as a remedial measure after failing to other noninvasive modes, including reducing the number of apneas, bradycardias or oxygen desaturations. However, there were rare randomized controlled studies comparing NHFOV with NCPAP in preterm infants with BPD.

We have found that NHFOV is superior to NCPAP in avoiding re-intubation in very preterm infants with the first extubation. The purpose of the present study was to compare NHFOV with NCPAP as post-extubation respiratory support strategies on the need for endotracheal ventilation, as well as pressure of CO2(PCO2) level in preterm infants with BPD.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria

Eligibility requirements for neonates:

  • The gestational age is less than 32 weeks
  • The preterm neonates are diagnosed with BPD and need invasive ventilation
  • Extubation and subsequent noninvasive ventilation is ready to be carried out
Exclusion Criteria

one of the following conditions is needed:

  • there were no intraventricular hemorrhage(IVH) grades 3 or 4
  • major congenital anomalies
  • parents' decision not to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NHFOVNHFOVAfter documenting parental consent, the ventilated infants with BPD were randomly assigned to NHFOV
NCPAPNCPAPAfter documenting parental consent, the ventilated infants with BPD were randomly assigned to NCPAP
Primary Outcome Measures
NameTimeMethod
deathseven days after extubation

the newborn infants with BPD die

re-intubation rateseven days after extubation

the newborn infants with ventilated BPD is reintubated after extubation

the level of carbon dioxideseven days after extubation

the level of carbon dioxide is measure after extubation between groups

Secondary Outcome Measures
NameTimeMethod
intraventricular hemorrhage(IVH)seven days after extubation

the newborn infants with BPD is diagnosed with NEC

necrotizing entercolitis(NEC)seven days after extubation

the newborn infants with BPD is diagnosed with NEC

Trial Locations

Locations (1)

Chen(陈)

🇨🇳

Chongqing, Chongqing, China

© Copyright 2025. All Rights Reserved by MedPath